Immunosenescence and Cytomegalovirus: Where do we stand after a decade?

Immunity and Ageing

Volumn 7, Issue , 2010, Pages

  Pawelec, Graham ^a   Akbar, Arne ^b   Beverley, Peter ^c   Caruso, Calogero ^d   Derhovanessian, Evelyna ^a   Fülöp, Tamas ^e   Griffiths, Paul ^b   Grubeck Loebenstein, Beatrix ^f   Hamprecht, Klaus ^a   Jahn, Gerhard ^a   Kern, Florian ^g   Koch, Sven D ^h   Larbi, Anis ^a   Maier, Andrea B ⁱ   Macallan, Derek ^j   Moss, Paul ^k   Samson, Sandrine ^l   Strindhall, Jan ^m   Trannoy, Emanuelle ^l   Wills, Mark ⁿ  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^g BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^l SANOFI PASTEUR   (France)

^m JÖNKÖPING UNIVERSITY   (Sweden)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN;

ADAPTIVE IMMUNITY; AGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOSENESCENCE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TH17 CELL;

EID: 77956468718     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-7-13     Document Type: Note

References (11)

1. Looney RJ, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999, 90:213-219. 10.1006/clim.1998.4638, 10080833.
2. Chidrawar S, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009, 155:423-432. 10.1111/j.1365-2249.2008.03785.x, 2669518, 19220832.
3. van de Berg PJ, et al. A fingerprint left by cytomegalovirus infection in the human T cell compartment. J Clin Virol 2008, 41:213-217. 10.1016/j.jcv.2007.10.016, 18061537.
4. Derhovanessian E, et al. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 2009, 21:440-445. 10.1016/j.coi.2009.05.012, 19535233.
5. Pawelec G, et al. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009, 19:47-56. 10.1002/rmv.598, 19035529.
6. Wikby A, et al. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 2008, 9:299-308. 10.1007/s10522-008-9138-6, 18369735.
7. Strandberg TE, et al. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301:380-382. 10.1001/jama.2009.4, 19176439.
8. Aiello AE, et al. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 2008, 63:610-618.
9. Hadrup SR, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
10. Nickel P, et al. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl Immunol 2009, 20:238-242. 10.1016/j.trim.2008.11.002, 19032982.
11. Pass RF, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009, 360:1191-1199. 10.1056/NEJMoa0804749, 2753425, 19297572.